Software - Application
Compare Stocks
3 / 10Stock Comparison
BRZE vs SPSC vs MANH
Revenue, margins, valuation, and 5-year total return — side by side.
Software - Infrastructure
Software - Application
BRZE vs SPSC vs MANH — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||
|---|---|---|---|
| Industry | Software - Application | Software - Infrastructure | Software - Application |
| Market Cap | $2.31B | $2.14B | $8.50B |
| Revenue (TTM) | $738M | $762M | $1.10B |
| Net Income (TTM) | $-131M | $91M | $217M |
| Gross Margin | 67.1% | 68.0% | 55.6% |
| Operating Margin | -19.6% | 15.3% | 25.6% |
| Forward P/E | 35.7x | 12.7x | 26.8x |
| Total Debt | $83M | $10M | $112M |
| Cash & Equiv. | $124M | $151M | $329M |
BRZE vs SPSC vs MANH — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Nov 21 | May 26 | Return |
|---|---|---|---|
| Braze, Inc. (BRZE) | 100 | 29.7 | -70.3% |
| SPS Commerce, Inc. (SPSC) | 100 | 40.5 | -59.5% |
| Manhattan Associate… (MANH) | 100 | 91.9 | -8.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BRZE vs SPSC vs MANH
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BRZE is the clearest fit if your priority is growth exposure.
- Rev growth 24.4%, EPS growth -19.6%, 3Y rev CAGR 27.6%
- 24.4% revenue growth vs MANH's 3.7%
SPSC is the clearest fit if your priority is income & stability and sleep-well-at-night.
- beta 1.03
- Lower volatility, beta 1.03, Low D/E 1.0%, current ratio 1.74x
- PEG 0.89 vs MANH's 1.25
MANH has the current edge in this matchup, primarily because of its strength in long-term compounding.
- 145.1% 10Y total return vs SPSC's 119.8%
- 19.7% margin vs BRZE's -17.8%
- -21.9% vs SPSC's -59.7%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 24.4% revenue growth vs MANH's 3.7% | |
| Value | Lower P/E (12.7x vs 26.8x), PEG 0.89 vs 1.25 | |
| Quality / Margins | 19.7% margin vs BRZE's -17.8% | |
| Stability / Safety | Beta 1.03 vs BRZE's 1.27, lower leverage | |
| Dividends | Tie | None of these 3 stocks pay a meaningful dividend |
| Momentum (1Y) | -21.9% vs SPSC's -59.7% | |
| Efficiency (ROA) | 28.0% ROA vs BRZE's -12.9%, ROIC 236.8% vs -20.5% |
BRZE vs SPSC vs MANH — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
BRZE vs SPSC vs MANH — Financial Metrics
Side-by-side numbers across 3 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
MANH leads in 3 of 6 categories
SPSC leads 1 • BRZE leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
MANH leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
MANH and BRZE operate at a comparable scale, with $1.1B and $738M in trailing revenue. MANH is the more profitable business, keeping 19.7% of every revenue dollar as net income compared to BRZE's -17.8%. On growth, BRZE holds the edge at +27.9% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||
|---|---|---|---|
| RevenueTrailing 12 months | $738M | $762M | $1.1B |
| EBITDAEarnings before interest/tax | -$131M | $162M | $288M |
| Net IncomeAfter-tax profit | -$131M | $91M | $217M |
| Free Cash FlowCash after capex | $61M | $167M | $380M |
| Gross MarginGross profit ÷ Revenue | +67.1% | +68.0% | +55.6% |
| Operating MarginEBIT ÷ Revenue | -19.6% | +15.3% | +25.6% |
| Net MarginNet income ÷ Revenue | -17.8% | +11.9% | +19.7% |
| FCF MarginFCF ÷ Revenue | +8.2% | +21.9% | +34.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | +27.9% | +5.8% | +7.4% |
| EPS Growth (YoY)Latest quarter vs prior year | -70.6% | -8.6% | -3.5% |
Valuation Metrics
SPSC leads this category, winning 6 of 7 comparable metrics.
Valuation Metrics
At 23.2x trailing earnings, SPSC trades at a 42% valuation discount to MANH's 39.9x P/E. Adjusting for growth (PEG ratio), SPSC offers better value at 1.62x vs MANH's 1.86x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||
|---|---|---|---|
| Market CapShares × price | $2.3B | $2.1B | $8.5B |
| Enterprise ValueMkt cap + debt − cash | $2.3B | $2.0B | $8.3B |
| Trailing P/EPrice ÷ TTM EPS | -18.52x | 23.24x | 39.88x |
| Forward P/EPrice ÷ next-FY EPS est. | 35.72x | 12.73x | 26.79x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.62x | 1.86x |
| EV / EBITDAEnterprise value multiple | — | 11.30x | 28.67x |
| Price / SalesMarket cap ÷ Revenue | 3.13x | 2.84x | 7.86x |
| Price / BookPrice ÷ Book value/share | 3.91x | 2.23x | 27.85x |
| Price / FCFMarket cap ÷ FCF | 37.34x | 14.04x | 22.74x |
Profitability & Efficiency
MANH leads this category, winning 6 of 8 comparable metrics.
Profitability & Efficiency
MANH delivers a 78.2% return on equity — every $100 of shareholder capital generates $78 in annual profit, vs $-23 for BRZE. SPSC carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to MANH's 0.36x. On the Piotroski fundamental quality scale (0–9), SPSC scores 6/9 vs BRZE's 3/9, reflecting solid financial health.
| Metric | |||
|---|---|---|---|
| ROE (TTM)Return on equity | -22.8% | +9.5% | +78.2% |
| ROA (TTM)Return on assets | -12.9% | +7.9% | +28.0% |
| ROICReturn on invested capital | -20.5% | +12.2% | +2.4% |
| ROCEReturn on capital employed | -23.4% | +12.5% | +76.3% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 6 | 6 |
| Debt / EquityFinancial leverage | 0.13x | 0.01x | 0.36x |
| Net DebtTotal debt minus cash | -$42M | -$141M | -$216M |
| Cash & Equiv.Liquid assets | $124M | $151M | $329M |
| Total DebtShort + long-term debt | $83M | $10M | $112M |
| Interest CoverageEBIT ÷ Interest expense | — | — | — |
Total Returns (Dividends Reinvested)
MANH leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MANH five years ago would be worth $10,805 today (with dividends reinvested), compared to $2,420 for BRZE. Over the past 12 months, MANH leads with a -21.9% total return vs SPSC's -59.7%. The 3-year compound annual growth rate (CAGR) favors MANH at -5.4% vs SPSC's -28.0% — a key indicator of consistent wealth creation.
| Metric | |||
|---|---|---|---|
| YTD ReturnYear-to-date | -30.6% | -35.0% | -14.2% |
| 1-Year ReturnPast 12 months | -30.7% | -59.7% | -21.9% |
| 3-Year ReturnCumulative with dividends | -20.7% | -62.6% | -15.3% |
| 5-Year ReturnCumulative with dividends | -75.8% | -41.9% | +8.1% |
| 10-Year ReturnCumulative with dividends | -75.8% | +119.8% | +145.1% |
| CAGR (3Y)Annualised 3-year return | -7.4% | -28.0% | -5.4% |
Risk & Volatility
Evenly matched — BRZE and SPSC each lead in 1 of 2 comparable metrics.
Risk & Volatility
SPSC is the less volatile stock with a 1.03 beta — it tends to amplify market swings less than BRZE's 1.27 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BRZE currently trades 60.0% from its 52-week high vs SPSC's 37.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||
|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.27x | 1.03x | 1.10x |
| 52-Week HighHighest price in past year | $37.67 | $153.16 | $247.22 |
| 52-Week LowLowest price in past year | $15.26 | $50.56 | $119.06 |
| % of 52W HighCurrent price vs 52-week peak | +60.0% | +37.3% | +58.1% |
| RSI (14)Momentum oscillator 0–100 | 47.6 | 46.9 | 50.6 |
| Avg Volume (50D)Average daily shares traded | 3.0M | 605K | 678K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Analyst consensus: BRZE as "Buy", SPSC as "Hold", MANH as "Buy". Consensus price targets imply 87.8% upside for BRZE (target: $42) vs 20.2% for SPSC (target: $69).
| Metric | |||
|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $42.44 | $68.71 | $197.25 |
| # AnalystsCovering analysts | 25 | 23 | 15 |
| Dividend YieldAnnual dividend ÷ price | — | — | — |
| Dividend StreakConsecutive years of raises | — | — | 2 |
| Dividend / ShareAnnual DPS | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +5.3% | +3.7% |
MANH leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). SPSC leads in 1 (Valuation Metrics). 1 tied.
BRZE vs SPSC vs MANH: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is BRZE or SPSC or MANH a better buy right now?
For growth investors, Braze, Inc.
(BRZE) is the stronger pick with 24. 4% revenue growth year-over-year, versus 3. 7% for Manhattan Associates, Inc. (MANH). SPS Commerce, Inc. (SPSC) offers the better valuation at 23. 2x trailing P/E (12. 7x forward), making it the more compelling value choice. Analysts rate Braze, Inc. (BRZE) a "Buy" — based on 25 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — BRZE or SPSC or MANH?
On trailing P/E, SPS Commerce, Inc.
(SPSC) is the cheapest at 23. 2x versus Manhattan Associates, Inc. at 39. 9x. On forward P/E, SPS Commerce, Inc. is actually cheaper at 12. 7x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: SPS Commerce, Inc. wins at 0. 89x versus Manhattan Associates, Inc. 's 1. 25x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — BRZE or SPSC or MANH?
Over the past 5 years, Manhattan Associates, Inc.
(MANH) delivered a total return of +8. 1%, compared to -75. 8% for Braze, Inc. (BRZE). Over 10 years, the gap is even starker: MANH returned +145. 1% versus BRZE's -75. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — BRZE or SPSC or MANH?
By beta (market sensitivity over 5 years), SPS Commerce, Inc.
(SPSC) is the lower-risk stock at 1. 03β versus Braze, Inc. 's 1. 27β — meaning BRZE is approximately 24% more volatile than SPSC relative to the S&P 500. On balance sheet safety, SPS Commerce, Inc. (SPSC) carries a lower debt/equity ratio of 1% versus 36% for Manhattan Associates, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — BRZE or SPSC or MANH?
By revenue growth (latest reported year), Braze, Inc.
(BRZE) is pulling ahead at 24. 4% versus 3. 7% for Manhattan Associates, Inc. (MANH). On earnings-per-share growth, the picture is similar: SPS Commerce, Inc. grew EPS 20. 6% year-over-year, compared to -19. 6% for Braze, Inc.. Over a 3-year CAGR, BRZE leads at 27. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — BRZE or SPSC or MANH?
Manhattan Associates, Inc.
(MANH) is the more profitable company, earning 20. 3% net margin versus -17. 8% for Braze, Inc. — meaning it keeps 20. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MANH leads at 26. 1% versus -19. 6% for BRZE. At the gross margin level — before operating expenses — BRZE leads at 67. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is BRZE or SPSC or MANH more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, SPS Commerce, Inc. (SPSC) is the more undervalued stock at a PEG of 0. 89x versus Manhattan Associates, Inc. 's 1. 25x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, SPS Commerce, Inc. (SPSC) trades at 12. 7x forward P/E versus 35. 7x for Braze, Inc. — 23. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BRZE: 87. 8% to $42. 44.
08Which pays a better dividend — BRZE or SPSC or MANH?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is BRZE or SPSC or MANH better for a retirement portfolio?
For long-horizon retirement investors, SPS Commerce, Inc.
(SPSC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 03), +119. 8% 10Y return). Both have compounded well over 10 years (SPSC: +119. 8%, BRZE: -75. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between BRZE and SPSC and MANH?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: BRZE is a small-cap high-growth stock; SPSC is a small-cap high-growth stock; MANH is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.